Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benjamin Edwards Inc. lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,362 shares of the biopharmaceutical company’s stock after selling 3,735 shares during the quarter. Benjamin Edwards Inc.’s holdings […]
Concentrum Wealth Management lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,766 shares of the biopharmaceutical company’s stock after acquiring an additional 413 shares during the quarter. […]
Brighton Jones LLC cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,152 shares of the biopharmaceutical company’s stock after selling 1,197 shares during the period. […]
Mission Wealth Management LP raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 12,086 shares of the biopharmaceutical company’s stock after acquiring an additional 1,367 shares during the period. Mission Wealth Management LP’s holdings in […]
Brighton Jones LLC decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 12,152 shares of the biopharmaceutical company’s stock after selling 1,197 shares during the quarter. Brighton Jones LLC’s holdings in Gilead Sciences were worth $984,000 at the […]